Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.950
-0.300 (-13.33%)
At close: Jul 30, 2026, 4:00 PM EDT
1.964
+0.014 (0.69%)
After-hours: Jul 30, 2026, 7:59 PM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $31.34 million as of July 30, 2026. Its market cap has decreased by -6.83% in one year.
Market Cap
31.34M
Enterprise Value
26.22M
1-Year Change
-6.83%
Ranking
Category
Stock Price
$1.95
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $31.34M, a decrease of -69.17%. That is a compound annual growth rate of -14.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 31.34M | -81.23% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 48.37M |
| BeyondSpring | 47.29M |
| Impact BioMedical | 47.18M |
| Eloxx Pharmaceuticals | 47.10M |
| aTyr Pharma | 46.08M |
| Metagenomi Therapeutics | 45.36M |
| Seres Therapeutics | 45.03M |
| INmune Bio | 44.93M |